FDA Grants Amgen License to Manufacture Enbrel, Neupogen, Neulasta at New Facilities and Protein Design Shares Shoot to 52-Week High on Positive Data for Heart Failure Drug
7th Sep 2005, 18:09 GMT
City of Industry, CA --(www.FinancialNewsUSA.com)-- 09/07/2005 - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Amgen Inc. (Nasdaq: AMGN), the nation's second-largest biotech firm, said Tuesday that regulators granted manufacturing licenses to two new facilities, setting it
Latest news from Financial News USA (OTC: FNWU):
- Overseas Building Supply Introduces 17 New Roof Tile Colors in High Gloss, Semi-Gloss and Natural Finishes and Fluor Named to G.I. Jobs' Top 50 Most Military Friendly Employer Ranking
- Chiquita Secures Amendment to Financial Covenants and Heinz Board Approves Majority Voting
- Barrick Extends Offer for Pioneer and NovaGold Comments on Barrick's Decision to Waive Minimum Tender Condition
- Merck Juggles Launch of 3 Vaccines and Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
- Boeing's Ridley Operation to Grow With $10B Chinook Contract and Lockheed Martin Appoints New Top Manager at Kelly Aviation Center
- Mexico's Televisa to Reveal Triple-Play Plan Soon and Univision's Latin GRAMMY(R) Broadcast Reaches 11.3 Million Viewers
- Vodafone Group to Offer Broadband Service Early in 2007 and UTStarcom Strengthens Management Team
- ADM Outlines Strategy for Growth in Bioenergy and Bunge Shares Rise on Upgrade
- Juniper Says IPv6 Transition Will Impact 30 Percent of U.S. Government IT Purchasing Decisions in 2007 and EarthLink Municipal Networks President Don Berryman Named Atlanta Telecom Professional of the Year 2006
- Harrah's Announces Adjustment of Conversion Price and Joel Robuchon at MGM Grand Receives Mobil Five-Star Rating From Mobil Travel Guide